These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3797685

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neurochemical aspects on aging and diseases with cognitive impairment.
    Gottfries CG.
    J Neurosci Res; 1990 Dec; 27(4):541-7. PubMed ID: 2079715
    [Abstract] [Full Text] [Related]

  • 5. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.
    Reinikainen KJ, Paljärvi L, Huuskonen M, Soininen H, Laakso M, Riekkinen PJ.
    J Neurol Sci; 1988 Mar; 84(1):101-16. PubMed ID: 2452858
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type.
    Gottfries CG, Karlsson I, Svennerholm L.
    Int Psychogeriatr; 1996 Mar; 8(3):365-72. PubMed ID: 9116173
    [Abstract] [Full Text] [Related]

  • 10. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.
    Arai H, Kosaka K, Iizuka R.
    J Neurochem; 1984 Aug; 43(2):388-93. PubMed ID: 6204013
    [Abstract] [Full Text] [Related]

  • 11. Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer's dementia.
    Gottfries CG.
    J Neural Transm Suppl; 1990 Aug; 30():33-43. PubMed ID: 2202785
    [Abstract] [Full Text] [Related]

  • 12. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.
    Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO.
    Arch Gen Psychiatry; 1999 Feb; 56(2):185-92. PubMed ID: 10025444
    [Abstract] [Full Text] [Related]

  • 13. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
    Nazarali AJ, Reynolds GP.
    Cell Mol Neurobiol; 1992 Dec; 12(6):581-7. PubMed ID: 1283363
    [Abstract] [Full Text] [Related]

  • 14. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P, Katzman R, Terry RD.
    Nature; 1980 Nov 20; 288(5788):279-80. PubMed ID: 6107862
    [Abstract] [Full Text] [Related]

  • 15. Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia.
    Ichimiya Y, Arai H, Kosaka K, Iizuka R.
    Acta Neuropathol; 1986 Nov 20; 70(2):112-6. PubMed ID: 3739621
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.
    Reinikainen KJ, Paljärvi L, Halonen T, Malminen O, Kosma VM, Laakso M, Riekkinen PJ.
    Neurobiol Aging; 1988 Nov 20; 9(3):245-52. PubMed ID: 3398991
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
    Nagai T, McGeer PL, Peng JH, McGeer EG, Dolman CE.
    Neurosci Lett; 1983 Apr 11; 36(2):195-9. PubMed ID: 6866327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.